Gains in the current understanding of managing neovascular AMD with brolucizumab
Abstract Background Unresolved retinal fluid and high injection burden are major challenges for patients with neovascular age-related macular degeneration. Brolucizumab addresses these challenges by providing robust vision gains and superior fluid resolution, with the potential for longer treatment...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2023-11-01
|
| Series: | Journal of Ophthalmic Inflammation and Infection |
| Online Access: | https://doi.org/10.1186/s12348-023-00369-8 |